Archive: Regulatory Issues and Their Impact on Evidence-Based Lab Medicine
39 views · Published 15 July 2014 · 55:37 · Indexed 10 November 2026
Channel: UW Video · 2014 · Education
Some research has suggested that up to 80% of the US health care dollar is driven by diagnostic tests. The world of in vitro diagnostic testing though is often a hidden part of clinical medicine. In this talk, Dr. Larry Kessler from the School of Public Health and Community Medicine at the University of Washington describes the US Food and Drug Administration's approach to classification of in vitro diagnostic devices FDA and their regulatory pathways. The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.
More from this channel
-
54:45
Archive: Usable Privacy and Security: Protecting People from Online Phishing Scams
-
58:27
Archive: Technology for Long-Term Care: Scaling Elder Care to the Next Billion
-
53:34
Archive: Closing the Innovation Gap
-
52:34
Archive: Hardness Amplification by Repetition
-
54:57
Archive: Network Coded Wireless Architecture
-
56:48
Archive: Computer Science Research for Global Development
-
58:16
Archive: Thinking Historically about Thinking Historically: Identity Politics to Ethical Action
-
27:18
Archive: Eastside Specialty Center: Coordination of Care